A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer

A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer

Abstract Background The aim of this study was to evaluate the efficacy and safety of nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer (NSCLC). Methods Chemotherapy-naïve patients with advanced NSCLC were eligible. In the phase I dose-escalation co...

Full description

Bibliographic Details
Main Authors: Yoshihiro Hattori, Yuko Kono, Shoichi Itoh, Takako Inoue, Yoshiko Urata, Yoshitaka Kawa, Rie Tohnai, Toru Kumagai, Kazumi Nishino, Ryuji Uozumi, Satoshi Morita, Shunichi Negoro, Fumio Imamura, Miyako Satouchi
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Cancer
Subjects:
Nab-paclitaxel
Cisplatin
Non-small-cell lung cancer
Chemotherapy-naïve patients
Online Access:https://doi.org/10.1186/s12885-020-6588-y

Similar Items

Similar Items